3Oliner J D,Kinzler K W,Mehzer P S,et al.Amplification of a gene encoding a p53-associated protein in human sarcomas[J].Nature,1992,358:80-3.
4Fakharzaden S S,Trusko S P,George D L.Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line[J].EMBO J,1991,10(6):1 565-9.
6Zhang M F,Zhang Z Y,Fu J,et al.Correlation between expression of p53,p21/WAFl,and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma[J].J Transl Med,2009,7(1):110.
7Schmidt M K,Tommiska J,Broeks A,et al.Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309,and p53 expression on survival of breast cancer patients[J].Breast Cancer Res,2009,11(6):89.
8Abdel-Fattah G,Yoffe B,Krishnan B,Khaoustov V,Itani K.MDM2/p53 protein expression in the development of colorectal adenocarcinoma[J].J Gastrointest Surg,2000,4(1):109-114.
9Liu W,He L,Ramirez J,Ratain M J.Interactions between MDM2 and TP53 Genetic Alterations,and Their Impact on Response to MDM2 Inhibitors andOther Chemotherapeutic Drugs in Cancer Cells[J].Clin Cancer Res,2009,15(24):7 602-7.
10Kamb A,Gruis N A,Weaver-Feldhaus J,et al A cell cycle regulator potentially involved in genesis of many tumor types[J].Science,1994,264:436.
3Iaquinta PJ,Lees JA.Life and death decisions by the E2F tran-scription factors[J].Curr Opin Cell Biol,2007,19(6):649-657.
4Verdaguer E,Susana Gde A,Clemens A,et al.Implication of thetranscription factor E2F-1 in the modulation of neuronal apoptosis[J].Biomed Pharmacother,2007,61(7):390-399.
5Lu M,Liu Z,Yu H,et al.Combined effects of E2F1 and E2F2polymorphisms on risk and early onset of squamous cell carcinomaof the head and neck[J].Mol Carcinog,2012:Epub ahead ofprint.
6Gulzar ZG,McKenney JK,Brooks JD.Increased expression of Nu-SAP in recurrent prostate cancer is mediated by E2F1[J].Onco-gene,2012:Epub ahead of print.
7Hsieh HY,Shieh JJ,Chen CJ,et al.Prodigiosin down-regulatesSKP2 to induce p27(KIP1)stabilization and antiproliferation inhuman lung adenocarcinoma cells[J].Br J Pharmacol,2012:Epub ahead of print.
8Han S,Park K,Bae BN,et al.E2F1 expression is related with thepoor survival of lymph node positive breast patients treated withfluorouracil,doxorubicin and cyclophosphamide[J].Breast canc-er Res Treat,2003,82(1):11-16.
9Haller F,Gunawan B,Heydebreck AV,et al.Prognostic role ofE2F1 and members of the CDKN2A network in gastrointestinalstromal tumors[J].Clin Cancer Res,2005,11(18):6589-6597.
10Tada T,Watanabe T,Kazama S,et al.Reduced p16 expressioncorrelates with lymphatic invasion in colorectal cancers[J].Hepatogastroenterology,2003,50(54):1756-1760.
